Nathan Hardy
Director of Finance/CFO chez SANA BIOTECHNOLOGY, INC.
Fortune : 5 M $ au 31/03/2024
Profil
Nathan Hardy's career history includes serving as the Chief Financial Officer & Executive Vice President at Sana Biotechnology, Inc. He previously worked at Amgen, Inc. as the Executive Director & Head-Corporate Finance from 2007 to 2017.
Prior to that, he was the Vice President-Finance at Juno Therapeutics, Inc. from 2017 to 2018.
Mr. Hardy holds an MBA from the University of Notre Dame and an undergraduate degree from the University of Utah.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
SANA BIOTECHNOLOGY, INC.
0,23% | 07/03/2024 | 511 250 ( 0,23% ) | 5 M $ | 31/03/2024 |
Postes actifs de Nathan Hardy
| Sociétés | Poste | Début |
|---|---|---|
| SANA BIOTECHNOLOGY, INC. | Director of Finance/CFO | 01/09/2018 |
Anciens postes connus de Nathan Hardy
| Sociétés | Poste | Fin |
|---|---|---|
| JUNO THERAPEUTICS INC | Director of Finance/CFO | 01/06/2018 |
| AMGEN INC. | Director/Board Member | 01/08/2017 |
Formation de Nathan Hardy
| University of Notre Dame | Masters Business Admin |
| University of Utah | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| AMGEN INC. | Health Technology |
| SANA BIOTECHNOLOGY, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Juno Therapeutics, Inc.
 Juno Therapeutics, Inc. BiotechnologyHealth Technology Juno Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of innovative cellular immunotherapy for the treatment of cancer. It offers platforms which includes chimeric antigen receptors and T-cell receptors. The company was founded by Hans Edgar Bishop, Lawrence Corey, Richard D. Klausner, Stan Riddell, Isabelle Riviere, and Robert Taylor Nelsen on August 5, 2013 and is headquartered in Seattle, WA. | Health Technology |
